about
Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicityInfluence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patientsLow Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar.Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenNucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study.Drug-induced acid-base disorders.Current treatment of hepatitis B virus infections.Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review.Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11.Cycloartenyl Ferulate Inhibits Paraquat-Induced Apoptosis in HK-2 Cells With the Involvement of ABCC1.Complications of Treatment in Youth with HIV.Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years.Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.Associations between plasma tenofovir concentration and renal function markers in HIV-infected women.
P2860
Q33551834-9D47444B-5604-483C-9E6F-82F9A5582D1DQ35607723-8831943B-345D-407E-809E-90E51B48E34DQ35753540-6CDD7B7C-02EF-45E6-8D7F-0FD9367AA4DCQ36070335-EB0D1D30-95F5-40ED-9B6C-F01327B44F8DQ37411624-BF04E03B-309A-42AB-9268-B6E6226FC898Q38265082-DBD20343-D5EC-4621-B722-07BC1B484B54Q38553056-C2692A8F-150F-44F1-9D75-29F62330B305Q38675944-91ACC073-051A-44CB-9ACA-ABC511D5CAFDQ38717612-5F475C0B-22F4-4F00-B3A7-A9A31D0F40C4Q38836232-AB43E498-8121-4E14-9DED-16D0D9077451Q38846571-5D6B9964-3069-4AE1-BBC3-1865689DEE25Q41224775-D9D6BFB0-5FDA-4A50-91ED-E7B9592BDACBQ41344883-5C79C55E-FAEE-45FB-A202-8303D3E92ABBQ41597280-FB9AE57F-B3C9-4EAD-B60C-96AEA83E5734Q41639431-B4294DE4-D3E3-48F3-9089-AFEF6208A72CQ42226593-BA137DB4-C65A-4B25-8A05-42B845BA3FBCQ42245194-AE2267C8-9100-432F-ABE2-5F52A0876F4EQ53756185-C9E051D6-F64F-4B91-824C-6E9FA6F7B537
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on tenofovir toxicity in the kidney.
@en
type
label
Update on tenofovir toxicity in the kidney.
@en
prefLabel
Update on tenofovir toxicity in the kidney.
@en
P2860
P1433
P1476
Update on tenofovir toxicity in the kidney.
@en
P2093
Andrew M Hall
P2860
P2888
P304
P356
10.1007/S00467-012-2269-7
P577
2012-08-10T00:00:00Z
P5875
P6179
1047164646